The Current Ratio as of September 2024 (TTM) for Cogent Biosciences, Inc. (COGT) is 9.25

According to Cogent Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.25. This represents a change of -1.08% compared to the average of 9.35 of the last 4 quarters.

Cogent Biosciences, Inc. (COGT) Historical Current Ratio (quarterly & annually)

How has COGT Current Ratio performed in the past?

The mean historical Current Ratio of Cogent Biosciences, Inc. over the last ten years is 8.81. The current 9.25 Current Ratio has changed 10.40% with respect to the historical average. Over the past ten years (40 quarters), COGT's Current Ratio was at its highest in in the March 2021 quarter at 28.16. The Current Ratio was at its lowest in in the September 2015 quarter at 0.

Cogent Biosciences, Inc. (COGT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cogent Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cogent Biosciences, Inc. (COGT) Average Current Ratio

How has COGT Current Ratio performed in the past?

The current Current Ratio of Cogent Biosciences, Inc. (COGT) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Cogent Biosciences, Inc. (COGT) Current Ratio vs. Peers

How is COGT’s Current Ratio compared to its peers?

Cogent Biosciences, Inc.’s Current Ratio is less than Larimar Therapeutics, Inc. (10.93), less than Kura Oncology, Inc. (14.94), greater than Kiniksa Pharmaceuticals, Ltd. (3.57), less than Cerevel Therapeutics Holdings, Inc. (10.22), less than IDEAYA Biosciences, Inc. (17.50), greater than AnaptysBio, Inc. (9.09), greater than MeiraGTx Holdings plc (2.36), less than Keros Therapeutics, Inc. (20.37), greater than Homology Medicines, Inc. (4.19), greater than Sana Biotechnology, Inc. (5.20), greater than Olema Pharmaceuticals, Inc. (9.13), less than Cullinan Oncology, Inc. (28.87), greater than aTyr Pharma, Inc. (6.07), greater than Zentalis Pharmaceuticals, Inc. (6.59), less than Syndax Pharmaceuticals, Inc. (10.50), greater than KalVista Pharmaceuticals, Inc. (8.55), greater than Mersana Therapeutics, Inc. (2.72), less than Ventyx Biosciences, Inc. (14.19), less than Protagonist Therapeutics, Inc. (13.73), greater than Verona Pharma plc (8.61),

Build a custom stock screener for Cogent Biosciences, Inc. (COGT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cogent Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cogent Biosciences, Inc. (COGT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cogent Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.